Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-05 Sale | 2026-10-07 5:02 pm | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 294 | $1.99 | $585 | 81,715 (Direct) | View |
| 2026-08-25 Sale | 2026-08-27 4:14 pm | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 14,036 | $2.2064 | $30,969 | 2,615,911 (Indirect Direct) | View |
| 2026-08-18 Sale | 2026-08-20 4:10 pm | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 101 | $2.01 | $203 | 18,033 (Direct) | View |
| 2026-08-18 Sale | 2026-08-20 4:09 pm | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 185 | $2.01 | $372 | 82,009 (Direct) | View |
| 2026-08-18 Sale | 2026-08-20 4:08 pm | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 400 | $2.01 | $804 | 52,592 (Direct) | View |
| 2026-08-18 Sale | 2026-08-20 4:07 pm | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 604 | $2.01 | $1,214 | 146,349 (Direct) | View |
| 2026-08-18 Sale | 2026-08-20 4:07 pm | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 1,713 | $2.01 | $3,443 | 2,629,947 (Indirect Direct) | View |
| 2026-08-04 Sale | 2026-08-06 4:34 pm | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 1,142 | $1.57 | $1,793 | 66,008 (Direct) | View |
| 2026-07-21 Sale | 2026-07-23 4:28 pm | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 573 | $1.76 | $1,008 | 82,194 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-31 Option Award | 2026-09-02 4:30 pm | N/A 2036-08-30 | Acrivon Therapeutics Inc. | ACRV | Levin Michaela Chief Business Officer | 160,000 | $0 | 160,000 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:32 pm | N/A 2036-06-16 | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 20,275 | $0 | 20,275 (Indirect) | View |
| 2026-06-17 Option Award | 2026-06-22 4:14 pm | N/A 2036-06-16 | Acrivon Therapeutics Inc. | ACRV | TOMSICEK MICHAEL JOHN Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:13 pm | N/A 2036-06-16 | Acrivon Therapeutics Inc. | ACRV | Shacham Sharon Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:11 pm | N/A 2036-06-16 | Acrivon Therapeutics Inc. | ACRV | Palani Santhosh Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:10 pm | N/A 2036-06-16 | Acrivon Therapeutics Inc. | ACRV | Magovcevic-Liebisch Ivana Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:09 pm | N/A 2036-06-16 | Acrivon Therapeutics Inc. | ACRV | DiRocco Derek Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:08 pm | N/A 2036-06-16 | Acrivon Therapeutics Inc. | ACRV | BAUM CHARLES M Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2026-05-21 Tax Withholding | 2026-05-26 4:09 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 13,729 | $1.79 | 2,631,660 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:59 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 9,366 | $0 | 12,238,762 (Indirect) | View |
| 2026-05-18 Option Award | 2026-05-20 4:36 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | TOMSICEK MICHAEL JOHN Director | 9,366 | $0 | 9,366 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:36 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Shacham Sharon Director | 9,366 | $0 | 9,366 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:35 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Palani Santhosh Director | 9,366 | $0 | 9,366 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:35 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Magovcevic-Liebisch Ivana Director | 9,366 | $0 | 9,366 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:33 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | DiRocco Derek Director | 9,366 | $0 | 9,366 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:33 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | BAUM CHARLES M Director | 9,366 | $0 | 9,366 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:31 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 14,227 | $0 | 18,134 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:30 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Mirza Mansoor Raza Chief Medical Officer | 38,817 | $0 | 38,817 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:30 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 49,830 | $0 | 82,767 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:30 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 46,167 | $0 | 67,150 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:29 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 38,584 | $0 | 52,992 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:29 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 72,981 | $0 | 146,953 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:29 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 252,801 | $0 | 2,645,389 (Direct) | View |
| 2026-05-14 Tax Withholding | 2026-05-18 4:11 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $1.92 | 3,907 (Direct) | View |
| 2026-05-14 Tax Withholding | 2026-05-18 4:11 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 184 | $1.92 | 32,937 (Direct) | View |
| 2026-05-14 Tax Withholding | 2026-05-18 4:11 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 404 | $1.92 | 14,408 (Direct) | View |
| 2026-05-14 Tax Withholding | 2026-05-18 4:10 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 613 | $1.92 | 73,972 (Direct) | View |
| 2026-05-14 Tax Withholding | 2026-05-18 4:10 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 1,743 | $1.92 | 2,392,588 (Direct) | View |
| 2026-04-22 Option Award | 2026-04-23 4:28 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 3,888,888 | $1.8 | 12,229,396 (Indirect) | View |
| 2026-04-17 Tax Withholding | 2026-04-21 5:05 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 558 | $1.78 | 33,121 (Direct) | View |